Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)
CNY 18.59
(-0.37%)
CNY 18.59
(-0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.21 Billion | 8.26 Billion | 6.64 Billion | 6.48 Billion | 5.38 Billion | 5.09 Billion |
| Cost of Revenue | 3.37 Billion | 3.11 Billion | 2.65 Billion | 2.35 Billion | 2.12 Billion | 2.05 Billion |
| Gross Profit | 4.83 Billion | 5.15 Billion | 3.98 Billion | 4.13 Billion | 3.26 Billion | 3.04 Billion |
| Operating Expenses | 3.89 Billion | 3.42 Billion | 3.32 Billion | 2.54 Billion | 2.14 Billion | 2.24 Billion |
| Selling, General and Administrative Expenses | 1.89 Billion | 1.91 Billion | 1.86 Billion | 1.54 Billion | 1.34 Billion | 1.69 Billion |
| Research and Development Expenses | 982.99 Million | 925.52 Million | 942.26 Million | 565.69 Million | 467.35 Million | 396.75 Million |
| Other Expenses | 877.37 Million | 587.66 Million | 525.25 Million | 433.08 Million | 326.4 Million | -317.99 Million |
| Cost and Expenses | 7.18 Billion | 6.53 Billion | 5.98 Billion | 4.89 Billion | 4.26 Billion | 4.29 Billion |
| Operating Income | 1.36 Billion | 1.54 Billion | 868.39 Million | 1.28 Billion | 824.37 Million | 475.23 Million |
| Interest Expense | 237.75 Million | 220.01 Million | 166.34 Million | 135.32 Million | 224.66 Million | 139.8 Million |
| Income Tax Expense | 283.07 Million | 332.89 Million | 306.28 Million | 220.75 Million | 154.03 Million | 22.34 Million |
| Earnings before Tax | 1.1 Billion | 1.5 Billion | 786.92 Million | 1.21 Billion | 760.86 Million | 157.24 Million |
| Net Income | 830.46 Million | 1.16 Billion | 487.53 Million | 929.81 Million | 569.59 Million | 107.51 Million |
| Earnings Per Share Basic | 0.57 | 0.81 | 0.34 | 0.64 | 0.39 | 0.08 |
| Earnings Per Share Diluted | 0.57 | 0.80 | 0.34 | 0.64 | 0.39 | 0.08 |
| Weighted Average Shares Outstanding | 1.45 Billion | 1.44 Billion | 1.45 Billion | 1.45 Billion | 1.45 Billion | 1.31 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.45 Billion | 1.45 Billion | 1.45 Billion | 1.45 Billion | 1.45 Billion | 1.31 Billion |
| Gross Margin | 0.59 | 0.62 | 0.60 | 0.64 | 0.61 | 0.60 |
| EBIT Margin | 0.26 | 0.30 | 0.24 | 0.29 | 0.28 | 0.15 |
| Profit Margin | 0.10 | 0.14 | 0.07 | 0.14 | 0.11 | 0.02 |
| EBITDA | 2.15 Billion | 2.45 Billion | 1.56 Billion | 1.85 Billion | 1.46 Billion | 669.89 Million |
| Earnings Before Tax Margin | 0.17 | 0.19 | 0.13 | 0.20 | 0.15 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.11 Billion | 2.59 Billion | 2.46 Billion | 2.07 Billion | 8.21 Billion | 1.91 Billion |
| Cost of Revenue | 757.55 Million | 1.03 Billion | 1 Billion | 740.81 Million | 3.28 Billion | 835.65 Million |
| Gross Profit | 1.36 Billion | 1.56 Billion | 1.46 Billion | 1.33 Billion | 4.92 Billion | 1.07 Billion |
| Operating Expenses | 939.5 Million | 1.03 Billion | 1.01 Billion | 945.89 Million | 3.47 Billion | 769.31 Million |
| Selling, General and Administrative Expenses | 1.07 Billion | 795.76 Million | 804.93 Million | 652.96 Million | - | 857.37 Million |
| Research and Development Expenses | 247.49 Million | 188.95 Million | 213.85 Million | 288.16 Million | - | 239.99 Million |
| Other Expenses | -382.57 Million | -54.7 Million | 2.61 Million | 941.13 Million | 877.37 Million | 25.71 Million |
| Cost and Expenses | 1.69 Billion | 2.07 Billion | 2.02 Billion | 1.86 Billion | 6.91 Billion | 1.6 Billion |
| Operating Income | 359.47 Million | 524.89 Million | 447.25 Million | 200.2 Million | 1.12 Billion | 230.29 Million |
| Interest Expense | 54.68 Million | 52.11 Million | 61.81 Million | 49.81 Million | 231.69 Million | 57.34 Million |
| Income Tax Expense | 71.93 Million | 104.17 Million | 97.9 Million | 88.28 Million | 283.07 Million | 72.13 Million |
| Earnings before Tax | 354.83 Million | 591.76 Million | 379.39 Million | 198.48 Million | 1.12 Billion | 222.5 Million |
| Net Income | 282.7 Million | 477.72 Million | 270.84 Million | 108.9 Million | 830.46 Million | 152.73 Million |
| Earnings Per Share Basic | 0.20 | 0.33 | 0.19 | 0.07 | - | 0.11 |
| Earnings Per Share Diluted | 0.20 | 0.33 | 0.19 | 0.07 | - | 0.11 |
| Weighted Average Shares Outstanding | 1.44 Billion | 1.46 Billion | 1.44 Billion | 1.48 Billion | 1.44 Billion | 1.44 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.44 Billion | 1.46 Billion | 1.44 Billion | 1.48 Billion | 1.44 Billion | 1.44 Billion |
| Gross Margin | 0.64 | 0.60 | 0.59 | 0.64 | 0.60 | 0.56 |
| EBIT Margin | 0.19 | 0.29 | 0.20 | 0.16 | - | 0.15 |
| Profit Margin | 0.13 | 0.18 | 0.11 | 0.05 | 0.10 | 0.08 |
| EBITDA | 409.52 Million | 752.08 Million | 486.93 Million | 332.6 Million | - | 291.76 Million |
| Earnings Before Tax Margin | 0.17 | 0.20 | 0.18 | 0.10 | 0.14 | 0.12 |
688076
601326
BEDMUTHA
688425
SSR
6615